No Detail Found!

Effect of 32p application combined with timolol maleate on circulating vascular endothelial growth factor and basic fibroblast growth factor in children with cutaneous hemangioma

Author(s)
Zongliang Li Department of Nuclear Medicine, Xingtai People's Hospital,Xingtai 054001,China
Rongxin Ma Department of Pharmacy, Xingtai People's Hospital,Xingtai 054001,China
Yan Wei Department of Nuclear Medicine, Xingtai People's Hospital,Xingtai 054001,China
Jianghua Zuo Department of Clinical Laboratory, Xingtai People's Hospital,Xingtai 054001,China
Abstract
The aim of this study was to investigate the effect of 32P application combined with timolol maleate on circulating vascular endothelial growth factor and basic fibroblast growth factor in children with cutaneous hemangioma. Eighty children with hemangioma treated in the Provincial Women and Children’s Hospital from May 2018 to April 2019 were enrolled in the study, including 37 males and 43 females. The children were randomized into two groups according to the experiment: the conventional treatment group (taking one tablet of propranolol) and the combination treatment group (topical application of timolol maleate and 32P application). mRNA expression of VEGF and TGF-b was increased in the conventional treatment group compared with the combination treatment group (P0.05). 32P application combined with timolol maleate has a good therapeutic effect on hemangiomas, which can reduce the expression of circulating vascular endothelial growth factor and basic fibroblast growth factor.
Publication Details
Page(s) 1091-1097
Published Journal: Pakistan Journal of Zoology, Volume: 55, Issue: 3, Year: 2023

Request the full text from PASTIC

Keywords
Hemangioma, Endothelial growth factor, Basic fibroblasts, 32 P application, Timolol maleate
0

Citations

0

Downloads

79

Views